Opus Capital Group, LLC Sellas Life Sciences Group, Inc. Transaction History
Opus Capital Group, LLC
- $685 Million
- Q1 2024
A detailed history of Opus Capital Group, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Opus Capital Group, LLC holds 200,600 shares of SLS stock, worth $238,714. This represents 0.03% of its overall portfolio holdings.
Number of Shares
200,600
Previous 135,000
48.59%
Holding current value
$238,714
Previous $143,000
41.96%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding SLS
# of Institutions
35Shares Held
8.03MCall Options Held
2.52MPut Options Held
24.7K-
Anson Funds Management LP Dallas, TX4.83MShares$5.75 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.8 Million0.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$367,0743.71% of portfolio
-
Black Rock Inc. New York, NY278KShares$331,0790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA273KShares$324,9440.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...